Loading...
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...
Saved in:
Published in: | Int J Mol Sci |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
MDPI
2020
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352536/ https://ncbi.nlm.nih.gov/pubmed/32604720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21124544 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|